rs61750595
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_000552.5(VWF):c.4975C>T(p.Arg1659*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000322 in 1,612,998 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000552.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152116Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000559 AC: 14AN: 250392Hom.: 0 AF XY: 0.0000665 AC XY: 9AN XY: 135374
GnomAD4 exome AF: 0.0000335 AC: 49AN: 1460882Hom.: 0 Cov.: 40 AF XY: 0.0000413 AC XY: 30AN XY: 726644
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152116Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74314
ClinVar
Submissions by phenotype
not provided Pathogenic:2Other:1
- -
This nonsense variant causes the premature termination of VWF protein synthesis. In addition, it has been reported in individuals affected with VWD Type 3 in the published literature (PMID: 20147343 (2010), 24712919 (2014), 18485763 (2008), 23834637 (2013), 28971901 (2017), 24675615 (2014)). Therefore, the variant is classified as pathogenic. -
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 35505650, 31050121, 25525159, 1301136, 31589614, 29423401, 23834637, 9845532, 24712919, 18485763, 20147343) -
Hereditary von Willebrand disease Pathogenic:2Other:1
- -
Variant summary: VWF c.4975C>T (p.Arg1659X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 5.6e-05 in 250392 control chromosomes. This frequency does not allow conclusions about variant significance. c.4975C>T has been reported in the literature as a homozygous or compound heterozygous genotype in multiple individuals affected with Von Willebrand Disease type 3 (example, Mohl_2011, Lapi_2022, Zhang_1992, Ahmad_2014). These data indicate that the variant is very likely to be associated with disease. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
The NM_000552.5(VWF):c.4975C>T variant in VWF is a nonsense variant predicted to cause substitution of arginine by a premature stop at codon 1659. This nonsense variant occurs in exon 28 of 52 of the only known transcript and is predicted to trigger nonsense-mediated decay. Loss of function is a known mechanism of disease in forms of VWD that are partially (Type 1) or completely (Type 3) deficient in the gene product (PVS1). The Grpmax filtering allele frequency in gnomAD v4.1 is 0.000006890 (based on 14/1179672 alleles in the European non-Finnish population), which is lower than the ClinGen VWD VCEP threshold of <0.0001 for (PM2_Supporting). A higher frequency is seen in the European Finnish population, and at least 3 Finnish patients with this variant (2 heterozygous and 1 homozygous) displayed phenotypes consistent with VWD, including pronounced bleeding tendency, low vWF levels, and low Factor VIII levels (PMID: 1415226). The variant co-segregates with VWD through at least 2 affected meioses in each of 2 families (PP1; PMID: 1415226). In summary, this variant meets the criteria to be classified as Pathogenic for hereditary von Willebrand disease. ACMG/AMP criteria applied as specified by the ClinGen von Willebrand disease Variant Curation Expert Panel: PVS1, PM2_Supporting, PP1. -
von Willebrand disease type 3 Pathogenic:2
- -
variant already reported in ClinVar -
von Willebrand disease type 1 Pathogenic:2
- -
- -
VWF-related disorder Pathogenic:1
The VWF c.4975C>T variant is predicted to result in premature protein termination (p.Arg1659*). This variant has been well documented to be pathogenic for autosomal recessive Von Willebrand disease 3 (Ahmad et al. 2014. PubMed ID: 24712919; Borràs et al. 2017. PubMed ID: 28971901. Table S4; Gupta et al. 2008. PubMed ID: 18485763). This variant is reported in 0.040% of alleles in individuals of European (Finnish) descent in gnomAD. Nonsense variants in VWF are expected to be pathogenic. This variant is interpreted as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at